Sosei Group Corporation

Sosei Group Corporationverified

SOLTF

Price:

$7.75

Market Cap:

$106.17B

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboratio...[Read more]

Industry

Biotechnology

IPO Date

2013-09-04

Stock Exchange

PNK

Ticker

SOLTF

The Enterprise Value as of November 2024 (TTM) for Sosei Group Corporation (SOLTF) is 126.26B

According to Sosei Group Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 126.26B. This represents a change of -22.03% compared to the average of 161.93B of the last 4 quarters.

Sosei Group Corporation (SOLTF) Historical Enterprise Value (quarterly & annually)

How has SOLTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Sosei Group Corporation over the last ten years is 354.77B. The current 126.26B Enterprise Value has changed 3.46% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Enterprise Value was at its highest in in the June 2016 quarter at 1.25T. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

354.77B

Median

189.25B

Minimum

84.98B

Maximum

1.00T

Sosei Group Corporation (SOLTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sosei Group Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 188.86%

Maximum Annual Enterprise Value = 1.00T

Minimum Annual Increase = -76.91%

Minimum Annual Enterprise Value = 84.98B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023141.22B66.18%
202284.98B-33.96%
2021128.68B22.57%
2020104.98B-31.89%
2019154.13B-76.91%
2018667.45B-3.87%
2017694.35B-30.63%
20161.00T188.86%
2015346.53B54.45%
2014224.37B20.85%

Sosei Group Corporation (SOLTF) Average Enterprise Value

How has SOLTF Enterprise Value performed in the past?

The current Enterprise Value of Sosei Group Corporation (SOLTF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

118.29B

5-year avg

122.80B

10-year avg

354.77B

Sosei Group Corporation (SOLTF) Enterprise Value vs. Peers

How is SOLTF’s Enterprise Value compared to its peers?

Sosei Group Corporation’s Enterprise Value is greater than Gain Therapeutics, Inc. (36.73M), greater than BioVie Inc. (26.84M), greater than IN8bio, Inc. (9.94M), greater than NewAmsterdam Pharma Company N.V. (1.09B), greater than Cue Biopharma, Inc. (70.94M), greater than uniQure N.V. (517.32M), greater than Rocket Pharmaceuticals, Inc. (1.52B), greater than Rhythm Pharmaceuticals, Inc. (3.33B), greater than Solid Biosciences Inc. (147.89M), greater than MeiraGTx Holdings plc (448.89M), greater than Apellis Pharmaceuticals, Inc. (3.59B), greater than Blueprint Medicines Corporation (6.13B), greater than Karuna Therapeutics, Inc. (12.43B), greater than Mirati Therapeutics, Inc. (3.91B), greater than Day One Biopharmaceuticals, Inc. (1.07B), greater than VectivBio Holding AG (848.58M), greater than AVROBIO, Inc. (-85302404.00), greater than Zura Bio Limited (90.25M), greater than Elevation Oncology, Inc. (2.36M), greater than Hepion Pharmaceuticals, Inc. (1.72M),

Build a custom stock screener for Sosei Group Corporation (SOLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sosei Group Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sosei Group Corporation (SOLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sosei Group Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Sosei Group Corporation's Enterprise Value?

What is the highest Enterprise Value for Sosei Group Corporation (SOLTF)?

What is the 3-year average Enterprise Value for Sosei Group Corporation (SOLTF)?

What is the 5-year average Enterprise Value for Sosei Group Corporation (SOLTF)?

How does the current Enterprise Value for Sosei Group Corporation (SOLTF) compare to its historical average?